Clinical Trial Update: A Gene Therapy Study in Patients With Gaucher Disease Type 1 [Phase 1]

View source ↗

Summary

A Phase 1 gene therapy study for Gaucher disease type 1 has completed, with Spur Therapeutics listed as the sponsor and the trial status as COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Drugs mentioned

• Unspecified gene therapy candidate

Snippet

Sponsor: Spur Therapeutics | Conditions: Gaucher Disease, Type 1 | Phase 1 | Status: COMPLETED